TOP STORIES
rheumatology
Rheumatoid arthritis

Patients anxious about DMARDs and COVID-19 risk


Patients with rheumatic diseases are concerned about their medications increasing the risk of COVID-19 disease, particularly those on combination csDMARDs or a b/tsDMARD, Australian research shows. A survey of 550 patients at the Monash Health Department of Rheumatology Department found...

Patients with rheumatic diseases are concerned about their medications increasing the risk of COVID-19 disease, particularly those on combination csDMARDs...

Read more